Safety and Tolerability of Bifidobacterium Longum Subspecies Infantis LMG11588 Supplementation in Healthy Term Infants

Editor(s):
M.R.Z. Capeding
L.C. M. Phee
C. Ming
C.I. Cercamond

Bifidobacterium longum subsp. infantis (B. infantis) is a unique probiotic as it is able to metabolize the full range of human milk oligosaccharide in breastfed infants. A recent trial evaluated healthy breastfed and formula-fed infants randomized to receive a placebo-control or a low or high dose B. infantis supplement for 8 weeks. Both the low and high dose of the B. infantis LMG11588 supplements were shown to support normal infant growth, be safe and well-tolerated.